Imaging evaluation of immature lung and pulmonary diseases in premature infants

Abstract

Respiratory diseases have become one of the leading causes of death in premature infants in China. Due to the application of prenatal glucocorticoid for the treatment of fetal lung maturation, pulmonary surfactant (PS), various types of respiratory support technologies, clinical diagnosis and treatment strategies for respiratory diseases are more effective, and the diagnosis and treatment of most of the common respiratory diseases of premature infants have their own guidelines and clinical pathways. At present, most of the clinical research hotspots of respiratory diseases focus on genes research, early intervention methods and precise diagnosis and treatment of immature lung and pulmonary diseases in premature infants. This article intends to elaborate on the pathological basis, imaging findings and outcomes of common pulmonary diseases in premature infants and immature lung, to explore the clinical value of imaging examination in pulmonary diseases of premature infants and immature lung, and to assist in the clinical implementation of accurate diagnosis and treatment of pulmonary diseases in premature infants. Key words: Respiratory distress syndrome, newborn; Bronchopulmonary dysplasia; Infant, premature, diseases; Immature lung; Lung diseases; Diagnosis, computer-assisted; Infant, premature